Daraxonrasib Doubles Pancreatic Cancer Survival, May Help Other Cancers
A phase 2 clinical trial of the experimental drug daraxonrasib demonstrated a significant survival benefit for patients with advanced pancreatic cancer, with participants living twice as long as those receiving ... Read More